We’re excited to share our upcoming presentations of two posters at the American Association for Cancer Research (AACR) Annual Meeting 2025, happening April 25-30 in Chicago, IL!
Xentech is willing to accelerate the preclinical development/validation of new anti-cancer therapeutics with a growing panel of highly predictive human tumor-based models and robust screening/profiling studies.
Looking forward to welcoming you at booth #538 or in front of the posters !